Joan Vlayen is a physician (1997, University of Leuven, Belgium) with a specialisation in Endocrinology (2003) and a certificate of hospital management. Since 2006 he has been working as an expert at the Belgian Health Care Knowledge Centre (KCE) where he is involved in several guideline, quality indicator and HTA projects and provides methodological support for literature reviews. In the past, he has worked for the Belgian Centre for Evidence Based Medicine (CEBAM). He was also a member of the ADAPTE collaboration, and recently joined the GRADE Working Group.
At the KCE, he is mainly involved in the development of guidelines and quality indicators in the domain of oncology. He participated at the EC funded CoCanCPG project, and helped to establish a long-term collaboration between KCE, IKNL and SIGN.
Vision for G-I-N over the next 5 years
Within 5 years, G-I-N should be a highly effective network where professionals involved in guideline development, dissemination and implementation have easy access to each other’s expertise. Networking should not be limited to one annual opportunity, but will need to be facilitated on a continuous basis by using modern communication techniques. G-I-N should also be the platform where methodological knowledge is easily exchanged and where support is provided continuously to less experienced organisations or individuals.
G-I-N should continue to explore collaboration with other international EBM organisations, such as the Cochrane Collaboration and EUnetHTA, in order to increase their complementarity. Within 5 years, G I-N should be the key source of information about guidelines.
Finally, G-I-N should invest more in international collaboration and joint guideline development, and initially focus on topics that are expected to have a high profit from collaboration, such as rare diseases. It should be a main focus of the Board to explore and implement various strategies to facilitate and support these collaborations.